Oxalate Nephropathy and Intravenous Vitamin C

被引:46
作者
Cossey, L. Nicholas [1 ]
Rahim, Fahim [2 ]
Larsen, Christopher P. [1 ,3 ]
机构
[1] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA
[2] Idaho Kidney Inst, Pocatello, ID USA
[3] Nephropath, Little Rock, AR USA
关键词
Oxalate; oxalosis; acute kidney injury; acute renal failure; alternative medicine; traditional medicine; vitamin C; ascorbic acid; lupus; systemic lupus erythematosus (SLE); TERMINAL HUMAN CANCER; PRIMARY HYPEROXALURIA; OXALOBACTER-FORMIGENES; SUPPLEMENTAL ASCORBATE; SUPPORTIVE TREATMENT; URINARY OXALATE; SURVIVAL TIMES; KIDNEY-STONES; RENAL-FAILURE; PROLONGATION;
D O I
10.1053/j.ajkd.2013.01.025
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Oxalate nephropathy is a rare condition characterized by extensive calcium oxalate deposition in the renal tubules, resulting in kidney injury. There are primary forms of the disease that arise from genetic mutation causing overproduction of oxalate. More commonly, this condition is seen as a secondary phenomenon. The clinical presentation is nonspecific, with acute kidney injury and normal serologic study results. The characteristic finding on kidney biopsy is the presence of acute tubular injury associated with polarizable crystals in the tubular lumen and epithelial cytoplasm. We present a case of acute oxalate nephropathy in a patient with underlying systemic lupus erythematosus who recently received intravenous vitamin C. (c) 2013 by the National Kidney Foundation, Inc.
引用
收藏
页码:1032 / 1035
页数:4
相关论文
共 30 条
[1]   OXALOBACTER-FORMIGENES GEN-NOV, SP-NOV - OXALATE-DEGRADING ANAEROBES THAT INHABIT THE GASTROINTESTINAL-TRACT [J].
ALLISON, MJ ;
DAWSON, KA ;
MAYBERRY, WR ;
FOSS, JG .
ARCHIVES OF MICROBIOLOGY, 1985, 141 (01) :1-7
[2]   SUPPLEMENTAL ASCORBATE IN SUPPORTIVE TREATMENT OF CANCER - PROLONGATION OF SURVIVAL TIMES IN TERMINAL HUMAN CANCER .1. [J].
CAMERON, E ;
PAULING, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (10) :3685-3689
[3]   SUPPLEMENTAL ASCORBATE IN SUPPORTIVE TREATMENT OF CANCER - RE-EVALUATION OF PROLONGATION OF SURVIVAL TIMES IN TERMINAL HUMAN CANCER [J].
CAMERON, E ;
PAULING, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (09) :4538-4542
[4]   Oxalate content of legumes, nuts, and grain-based flours [J].
Chai, WW ;
Liebman, M .
JOURNAL OF FOOD COMPOSITION AND ANALYSIS, 2005, 18 (07) :723-729
[5]   HISTOPATHOLOGICAL OCCURRENCE AND CHARACTERIZATION OF CALCIUM-OXALATE - REVIEW [J].
CHAPLIN, AJ .
JOURNAL OF CLINICAL PATHOLOGY, 1977, 30 (09) :800-811
[6]   MEDICAL PROGRESS - THE PATHOGENESIS AND TREATMENT OF KIDNEY-STONES [J].
COE, FL ;
PARKS, JH ;
ASPLIN, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16) :1141-1152
[7]  
Danpure C.J., 2011, The Metabolic and Molecular Bases of Inherited Disease, V15, P1, DOI DOI 10.4061/2011/864580
[8]   Nephrocalcinosis and urolithiasis in children [J].
Habbig, Sandra ;
Beck, Bodo Bernhard ;
Hoppe, Bernd .
KIDNEY INTERNATIONAL, 2011, 80 (12) :1278-1291
[9]   Oxalobacter sp reduces urinary oxalate excretion by promoting enteric oxalate secretion [J].
Hatch, M ;
Cornelius, J ;
Allison, M ;
Sidhu, H ;
Peck, A ;
Freel, RW .
KIDNEY INTERNATIONAL, 2006, 69 (04) :691-698
[10]   Intestinal transport of an obdurate anion: oxalate [J].
Hatch, M ;
Freel, RW .
UROLOGICAL RESEARCH, 2005, 33 (01) :1-16